Veradermics, Inc. (MANE)
97.93
-3.88
(-3.81%)
USD |
NYSE |
Aug 28, 16:00
98.06
+0.13
(+0.13%)
After-Hours: 20:00
Veradermics Price to Book Value : 5.025 for Aug. 28, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 28, 2026 | 5.025 |
| August 27, 2026 | 5.224 |
| August 26, 2026 | 5.275 |
| August 25, 2026 | 5.252 |
| August 24, 2026 | 5.052 |
| August 21, 2026 | 5.276 |
| August 20, 2026 | 5.404 |
| August 19, 2026 | 5.708 |
| August 18, 2026 | 5.712 |
| August 17, 2026 | 5.553 |
| August 14, 2026 | 5.784 |
| August 13, 2026 | 5.696 |
| August 12, 2026 | 5.596 |
| August 11, 2026 | 5.591 |
| August 10, 2026 | 5.683 |
| August 07, 2026 | 5.870 |
| August 06, 2026 | 5.575 |
| August 05, 2026 | 5.713 |
| August 04, 2026 | 5.505 |
| August 03, 2026 | 5.228 |
| July 31, 2026 | 5.388 |
| July 30, 2026 | 5.369 |
| July 29, 2026 | 5.530 |
| July 28, 2026 | 5.724 |
| July 27, 2026 | 5.717 |
| Date | Value |
|---|---|
| July 24, 2026 | 5.619 |
| July 23, 2026 | 5.945 |
| July 22, 2026 | 5.637 |
| July 21, 2026 | 5.618 |
| July 20, 2026 | 5.441 |
| July 17, 2026 | 5.712 |
| July 16, 2026 | 5.430 |
| July 15, 2026 | 6.348 |
| July 14, 2026 | 5.653 |
| July 13, 2026 | 5.654 |
| July 10, 2026 | 6.137 |
| July 09, 2026 | 6.410 |
| July 08, 2026 | 6.068 |
| July 07, 2026 | 5.993 |
| July 06, 2026 | 6.264 |
| July 02, 2026 | 6.657 |
| July 01, 2026 | 6.593 |
| June 30, 2026 | 6.308 |
| June 29, 2026 | 11.78 |
| June 26, 2026 | 12.09 |
| June 25, 2026 | 11.37 |
| June 24, 2026 | 11.18 |
| June 23, 2026 | 9.872 |
| June 22, 2026 | 9.795 |
| June 18, 2026 | 8.945 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Eli Lilly & Co. | 32.64 |
| EyePoint, Inc. | 2.288 |
| Elanco Animal Health, Inc. | 1.828 |
| Tarsus Pharmaceuticals, Inc. | 8.956 |
| Amylyx Pharmaceuticals, Inc. | 16.18 |
Price to Book Value Related Metrics
| PEG Ratio | -0.1066 |
| Price | 97.93 |
| Earnings Yield | -2.66% |
| Market Cap | 4.092B |
| PEGY Ratio | -0.1066 |